| Current Price | $49.86 | Mkt Cap | $1.0B |
|---|---|---|---|
| Open | $49.40 | P/E Ratio | 87.13 |
| Prev. Close | $49.86 | Div. (Yield) | $0.24 (0.5%) |
| Daily Range | $49.07 - $50.55 | Volume | 130,932 |
| 52-Wk Range | $35.18 - $57.96 | Avg. Daily Vol. | 112,673 |
The Company currently offers four software products for pharmaceutical research: ADMET Predictor/ ADMET Modeler, ClassPharmer, DDDPlus, and GastroPlus.
| Current Price | $49.86 | Mkt Cap | $1.0B |
|---|---|---|---|
| Open | $49.40 | P/E Ratio | 87.13 |
| Prev. Close | $49.86 | Div. (Yield) | $0.24 (0.5%) |
| Daily Range | $49.07 - $50.55 | Volume | 130,932 |
| 52-Wk Range | $35.18 - $57.96 | Avg. Daily Vol. | 112,673 |
The best Bull and Bear pitches based on recency and number of recommendations.
Market overestimating the addressable market of their product. Valuation can only be justified if historical growth rates are sustained for a significant period of time, but these growth rates are clearly unsustainble.
Read the most recent pitches from players about SLP.
Recs
RBtollesonAZ
(28.47)
Submitted: 11/18/2021 8:33:20 PM :
Start Price:
$56.47
NASDAQ:SLP Score:
+7.04
Continued biotech headwinds , one huge breakthrough in Crisper and off to the races
Recs
frederickdouglas
(< 20)
Submitted: 12/28/2020 8:33:42 PM :
Start Price:
$72.80
NASDAQ:SLP Score:
-33.56
Just tracking
Recs
cutchemist42
(71.12)
Submitted: 9/10/2020 11:18:57 AM :
Start Price:
$67.94
NASDAQ:SLP Score:
-38.65
Feroldi....similar to SDGR but more drug development and high margin consulting
Find the members with the highest scoring picks in SLP.
StangLX718 (84.47) Score: +2,471.23
The Score Leader is the player with the highest score across all their picks in SLP.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| eversuhoshin | 77.22 | 7/9/2010 |
|
5Y | $1.88 | +2,554.49% | +255.94% | +2,298.54 | 0 Comment | |
| marc021248 | 46.07 | 7/20/2010 |
|
5Y | $1.95 | +2,457.61% | +258.22% | +2,199.40 | 0 Comment | |
| alley11 | 59.38 | 7/8/2010 |
|
5Y | $1.97 | +2,426.75% | +256.37% | +2,170.37 | 0 Comment | |
| browns31 | < 20 | 7/14/2010 |
|
1Y | $1.98 | +2,416.54% | +249.13% | +2,167.41 | 1 Comment | |
| Southoftheborder | 47.75 |
|
|
5Y | $2.08 | +2,300.98% | +206.55% | +2,094.43 | 0 Comment | |
| Pepe150 | < 20 | 1/12/2011 |
|
1Y | $2.18 | +2,187.67% | +197.42% | +1,990.25 | 1 Comment | |
| stratisticalarb | 25.69 | 5/6/2011 |
|
1Y | $2.33 | +2,039.73% | +184.04% | +1,855.69 | 0 Comment | |
| pureoncharts | 65.88 | 1/18/2011 |
|
3W | $2.32 | +2,047.66% | +195.19% | +1,852.47 | 0 Comment | |
| kitenio | 85.05 | 11/3/2010 |
|
1Y | $2.43 | +1,949.35% | +219.00% | +1,730.35 | 0 Comment | |
| anguijm | 71.70 | 4/25/2011 |
|
5Y | $2.54 | +1,859.96% | +185.25% | +1,674.71 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
